APA (7th ed.) Citation

A, D., B, A., I, Y., H, D., E, S., F, H., . . . AS, Y. (2020). The impact of CYP2D6*4 and GSTP1 Ile105Val polymorphisms on the susceptibility to develop BCR-ABL1 negative myeloproliferative neoplasms. Molecular biology reports, 47(10), 7413. https://doi.org/10.1007/s11033-020-05796-7

Chicago Style (17th ed.) Citation

A, Daglar-Aday, Akadam-Teker B, Yonal-Hindilerden I, Dermenci H, Sahin E, Hindilerden F, Yilmaz-Aydogan H, Ozturk O, and Yavuz AS. "The Impact of CYP2D6*4 and GSTP1 Ile105Val Polymorphisms on the Susceptibility to Develop BCR-ABL1 Negative Myeloproliferative Neoplasms." Molecular Biology Reports 47, no. 10 (2020): 7413. https://doi.org/10.1007/s11033-020-05796-7.

MLA (9th ed.) Citation

A, Daglar-Aday, et al. "The Impact of CYP2D6*4 and GSTP1 Ile105Val Polymorphisms on the Susceptibility to Develop BCR-ABL1 Negative Myeloproliferative Neoplasms." Molecular Biology Reports, vol. 47, no. 10, 2020, p. 7413, https://doi.org/10.1007/s11033-020-05796-7.